Group One Trading
SUPN icon

Group One Trading’s Supernus Pharmaceuticals SUPN Stock Holding History

Group One Trading’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$129K Buy
+2,500
New +$127K ﹤0.01% 4493
2025
Q4 		– Sell
-1,800
Closed -$86K – 9125
2025
Q3 		$86K Sell
1,800
-800
-31% -$32.2K ﹤0.01% 5480
2025
Q2 		$82K Sell
2,600
-6,200
-70% -$199K ﹤0.01% 5148
2025
Q1 		$288K Buy
8,800
+3,800
+76% +$135K ﹤0.01% 3648
2024
Q4 		$181K Buy
5,000
+3,300
+194% +$116K ﹤0.01% 4016
2024
Q3 		$53K Buy
+1,700
New +$53.1K ﹤0.01% 4625
2024
Q1 		– Sell
-900
Closed -$26K – 7942
2023
Q4 		$26K Buy
900
+800
+800% +$21.2K ﹤0.01% 5548
2023
Q3 		$2.76K Buy
+100
New +$3.04K ﹤0.01% 6941
2022
Q3 		– Sell
-300
Closed -$9K – 8231
2022
Q2 		$9K Hold
300
– – ﹤0.01% 6831
2022
Q1 		$10K Hold
300
– – ﹤0.01% 7173
2021
Q4 		$9K Sell
300
-400
-57% -$12.1K ﹤0.01% 7418
2021
Q3 		$19K Sell
700
-6,100
-90% -$164K ﹤0.01% 7215
2021
Q2 		$209K Buy
6,800
+5,100
+300% +$156K ﹤0.01% 5209
2021
Q1 		$45K Sell
1,700
-600
-26% -$16.8K ﹤0.01% 6305
2020
Q4 		$58K Buy
2,300
+1,700
+283% +$36.6K ﹤0.01% 4921
2020
Q3 		$13K Sell
600
-43,800
-99% -$994K ﹤0.01% 5328
2020
Q2 		$1.05M Sell
44,400
-17,400
-28% -$384K ﹤0.01% 1971
2020
Q1 		$1.11M Buy
61,800
+32,500
+111% +$683K 0.01% 1450
2019
Q4 		$695K Sell
29,300
-73,400
-71% -$1.78M ﹤0.01% 2170
2019
Q3 		$2.82M Buy
102,700
+77,700
+311% +$2.3M 0.02% 954
2019
Q2 		$827K Buy
25,000
+1,100
+5% +$37.7K 0.01% 1725
2019
Q1 		$837K Buy
23,900
+12,500
+110% +$465K 0.01% 1537
2018
Q4 		$379K Sell
11,400
-1,000
-8% -$43K ﹤0.01% 2187
2018
Q3 		$624K Sell
12,400
-5,100
-29% -$252K ﹤0.01% 2098
2018
Q2 		$1.05M Buy
17,500
+13,500
+338% +$699K 0.01% 1683
2018
Q1 		$183K Sell
4,000
-600
-13% -$25K ﹤0.01% 2860
2017
Q4 		$183K Sell
4,600
-43,000
-90% -$1.7M ﹤0.01% 2975
2017
Q3 		$1.9M Sell
47,600
-9,400
-16% -$407K 0.02% 1084
2017
Q2 		$2.46M Sell
57,000
-19,100
-25% -$680K 0.03% 832
2017
Q1 		$2.38M Buy
76,100
+53,600
+238% +$1.44M 0.03% 758
2016
Q4 		$568K Sell
22,500
-6,100
-21% -$136K 0.01% 1678
2016
Q3 		$707K Sell
28,600
-20,600
-42% -$466K 0.01% 1543
2016
Q2 		$1M Sell
49,200
-500
-1% -$8.87K 0.01% 1260
2016
Q1 		$758K Sell
49,700
-24,800
-33% -$324K 0.01% 1383
2015
Q4 		$1M Sell
74,500
-7,800
-9% -$121K 0.01% 1323
2015
Q3 		$1.16M Buy
82,300
+17,200
+26% +$320K 0.02% 1140
2015
Q2 		$1.1M Sell
65,100
-66,500
-51% -$946K 0.02% 1140
2015
Q1 		$1.59M Buy
131,600
+24,400
+23% +$231K 0.03% 772
2014
Q4 		$890K Sell
107,200
-9,200
-8% -$77.3K 0.01% 1144
2014
Q3 		$1.01M Buy
116,400
+7,200
+7% +$65K 0.02% 1110
2014
Q2 		$1.2M Buy
109,200
+26,600
+32% +$237K 0.02% 1013
2014
Q1 		$738K Buy
+82,600
New +$761K 0.01% 1328
2013
Q4 		– Sell
-815,400
Closed -$5.98M – 5524
2013
Q3 		$5.98M Buy
815,400
+688,800
+544% +$4.63M 0.11% 170
2013
Q2 		$814K Buy
+126,600
New +$746K 0.02% 971

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's SUPN Position: Q1 2026 in Review

Group One Trading sold out of Supernus Pharmaceuticals (SUPN) in Q1 2026, closing a stake of 331 shares — an estimated $16.9K sold.

Group One Trading first reported a position in SUPN in Q4 2013 and held it in 28 quarters. The position peaked at $2.95M in Q1 2014. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • Group One Trading reported no remaining Supernus Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 331 Supernus Pharmaceuticals shares in Q1 2026, an estimated $16.9K.
  • Group One Trading first reported a position in Supernus Pharmaceuticals in Q4 2013 and held it in 28 quarters.
  • Group One Trading's Supernus Pharmaceuticals position peaked at $2.95M in Q1 2014.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.